Jacob Van Naarden is the President of Loxo@Lilly, Eli Lillys oncology division. He joined Lilly in 2019 following the acquisition of Loxo Oncology, where he was Chief Operating Officer. His career includes roles in biotechnology investing and investment banking at firms like Goldman Sachs. He earned his bachelors degree in Molecular Biology from Princeton University.
There is no publicly available information regarding Jacob Van Naardens personal life, interests, or hobbies outside of his professional career in oncology and biotechnology.
He played a key role in establishing Loxo@Lilly after the acquisition, aiming to merge the speed of a biotech with the resources of a large pharmaceutical company.
Jacob Van Naarden
President at Eli Lilly and Company
Stamford, Connecticut, United States
Overview
Topics They Care About
Oncology Drug Development
As President of Loxo@Lilly, he oversees all aspects of oncology, from discovery and research through commercial development.
Biotech M&A
He joined Eli Lilly through the multi-billion dollar acquisition of Loxo Oncology, where he was COO, and now leads corporate business development for his division.
Radiopharmaceuticals
He has publicly stated that Lilly's acquisition of POINT Biopharma is the beginning of the company's investment into radioligand medicines for hard-to-treat cancers.
Media Appearances
Jacob has no verified media appearances
Work History
9-2021
President at Eli Lilly and Company
8-2021
President, Lilly Oncology at Eli Lilly and Company
1-2021
Chief Executive Officer at Loxo Oncology at Lilly
1-2019 - 1-2021
Chief Operating Officer at Loxo Oncology at Lilly
12-2015 - 1-2019
Chief Business Officer at Loxo Oncology at Lilly
5-2014 - 12-2015
VP, Corporate Development and Strategy at Loxo Oncology at Lilly
6-2013 - 5-2014
Analyst at HealthCor Management
8-2008 - 6-2013
Associate at Aisling Capital
7-2006 - 6-2008
Analyst at Goldman Sachs
Education
2002 - 2006
B.A. in Molecular Biology from Princeton University
More Information
Social Presence :
Prographics :
Exp : 19
Location : Stamford, Connecticut, United States
Job Level : Leadership
Designation : President at Eli Lilly and Company
